• TONX

  Led · Equity · Aug 2024

  TONX is a contributors team working on the TON blockchain. The company announced a $4.0 million financing on Aug 8, 2024. The round was led by SNZ Ventures and Summer Ventures. The report (via BlockTempo, carried by Foresight News) names those lead investors but does not list other participants. The article does not specify the financing instrument, valuation, revenue, user metrics, product roadmap, or future plans.

• Zeek Network

  Participated · Seed · Jun 2024

  Zeek is a decentralized collaboration network that uses on-chain social-bounty mechanics to generate a reputation layer for users. Its core product uses ‘Wishes’ (on-chain bounties) to surface opportunities for information, connections, and contributions. User contributions generate ‘Rizz’, a measurable reputation metric intended to be monetized and to signal credibility and influence. The product is powered by OpenSocial Protocol and the team has designed a token to foster collaboration and on-chain reputation construction. Zeek is currently in Private Beta and is preparing for an official launch in July, with pre-registration open via X and Discord. The company plans a Tier-0 Genesis NFT drop, limited to 250, later this month.

• Open Social

  Participated · Seed · May 2024

  OpenSocial Protocol provides open-source, modular social infrastructure and tooling (feed, chatrooms, posts, on-chain social graphs, tribes, megaphones and plug-ins such as token issuance, DAO tools, bounties and mini-games) to let creators and communities compose apps quickly and economically. The stack supports both on-chain and off-chain features and emphasizes true ownership of intellectual property, community relationships, and aligned monetization. The project is built by Everest Ventures Group and aims to deploy its infrastructure across major chains while offering a customizable UI layer for creators, moderators, and users. Early product traction includes SoMon, the first app on the protocol, which reached over 30,000 onchain active users in two weeks, ~20 minutes average engagement, and over 300,000 onchain transactions (excluding spam bots). EVG has deployed ~80 developers to develop the infrastructure and OpenSocial aims to help empower and launch 1,000 community apps by 2025. Financially, OpenSocial has raised a total of $26 million to date (a prior $5 million seed round plus $15 million in ecosystem funds, and the new $6 million strategic backing). OpenSocial Protocol is a composable infrastructure layer for building social applications that enables developers and creators to build multichain SocialFi dApps. It provides UI-layer composabilities, ownership of intellectual property and relationships, and monetisation and financial incentives for communities. The protocol has launched its first dApp, SoMon, a decentralized topic-based forum owned by users and communities with degen mechanics and sustainable rewards. Everest Ventures Group (EVG) founded OpenSocial and has set aside a $15M ecosystem fund to support developer adoption; there are 50 additional developers building dApps on OpenSocial outside of EVG. The company says it will use the new funding to expand operations and development efforts. OpenSocial aims to improve community dApps through composable infrastructure and UI-layer building blocks.

• Edifice Health

  Participated · Equity · Apr 2021

  Edifice Health applies novel proteomic approaches combined with proprietary artificial intelligence and predictive analysis to measure the rate at which an individual’s body ages. The company created a metric to measure systemic chronic inflammation, which Stanford Project research identified as a root cause and predictor of multiple chronic diseases of aging. Edifice has identified interventional supplements that can be targeted to an individual’s immunotype to improve inflammatory health and support healthy aging. The company was born out of the Stanford 1,000 Immunomes Project following NIH-funded research in immunological health and aging at Stanford University. Led by Chairman and CEO Wolfgang Daum, PhD, with founder David Furman, PhD active on the board, Edifice is building its scientific foundation and product capabilities. The company intends to use the new funding to grow its immunological science and add additional talent.

No current team members are available.